CV Michael Hecht Olsen Education and positions 1992: Medical degree, Grade 11.1, The University of Copenhagen (KU) 1999: PhD at KU: ”A Vascular relationship between hypertension and insulin resistance” 2007: Specialist in Cardiology April 2007 2007-11 Chief physician in Cardiology at Dept. Internal Medicine, Glostrup Hospital (GH). 2008-14 Associate professor, KU 2009: DMSc at KU: “New Cardiovascular Risk Markers” 2012-: Professor extraordinaire, HART, North-West University, South Africa 2011-16 Professor in Hypertension, University of Southern Denmark (SDU) 2011-16 Chief physician, Hypertension Clinic, Dept. of Endocrinology, OUH. 2016-17: Associate professor, SDU 2016-: Chief physician, Hypertension Clinic, Dept. of Internal Medicine, Holbæk Hospital. 2018-: Professor in Hypertension and Cardiovascular Prevention, SDU Tutoring I have been main tutor for five medical students doing OSVAL II or candidate projects as well as tutor for ten PhD students of which I was principal tutor for seven. Currently I have five PhD students of which I am principal tutor for two. Coordination 2006-12: Board member of the Danish Hypertension Society 2007-15: Council member of European Society of Hypertension (ESH) 2009-12: Member of the editorial board of Journal Hypertension 2012-: President of the Program for Research Education for Heart, Kidney and Circulation at SDU 2012-: Member of the Steering committee of Centre for Individualized Medicine in Arterial Diseases (CIMA) 2014-17: Member of the Council on Hypertension of European Society of Cardiology 2014-: Member of the Steering committee of The Danish Cardiovascular Screening Trial (DANCAVAS) 2015-: Member of the Steering committee of Cardiovascular Centre of Excellence (CAVAC) 2015-: Head of a Lancet Commission on Hypertension (Lancet 2015; 386(9994): 637-638) Financial support 2002 Kaj and Allis Bunch-Jensens honorary for contribution to cardiovascular research in DK 2005 The AstraZeneca Price from Danish Society of Hypertension 2005 The Hans Ibsen Foundation to strengthen research in hypertension 2008 A 5-year Clinical Research Stipendium from Novo Nordic Foundation (2,500,000 DKkr). 2008 European Society of Hypertensions two-year Fellowship - Research Grant for Thomas Sehestedt to do his PhD (100,000 Euro). 2008 Support to a Nordic Ph.D. meeting from The joint Committee of the Nordic Medical Research Councils (NOS-M) (32,000 Euro). 2010 One year Scholar stipendium from Lundbeck Foundation for medical student Thomas Sehested (120,000 DKkr.). 2010 EU funding through Interreg to a research cooperation in the region of Oeresund with Rigshospitalet, Malmoe Hospital and University of Lund (1,900,000 Euro). 2011 Two one year PhD stipendium (1,050,000 DKkr.) from Novo Nordic Foundation and OUH for Marie K. Blicher and her PhD project: Catheter based Renal denervation in patients with Resistant hypertension – Effects on kidney, Vasculature and Insulin SEnsitivity (REVISE) 2012 A one year PhD stipendium (500,000 DKkr.) and financial support (935,633 DKKr.) from the Region of Southern Denmark for Sara Vikström and her PhD project: SubclinicAl Target Organ damage – a Marker of Individual Cardiovascular Susceptibility (ATOMICS) 2012 Two one year PhD stipendium from SDU (1,000,000 DKkr.) for Marie K. Blicher and Sara Vikström and their PhD projects: REVISE and ATOMICS 2012 Financial support from Odense University Hospital (OUH) (453,500 DKkr.) to the PhD project ATOMICS 2012 European Society of Hypertensions two-year Fellowship - Research Grant for Sara Vikström to do her PhD and start GIRO-TOPIC (100,000 Euro). 2012 Coapplicant for CIMA supported by OUH with 14,000,000 DKkr. over 5 years. 2013 A 5-year Clinical Research Stipendium from Novo Nordic Foundation (2,500,000 DKkr) 2013 Financial support from The Danish Heart Foundation (475,000 DKkr.) and OUH (500,000 DKkr.) for the PhD project REVISE 2013 Financial support from OUH (665,000 DKkr.) for Manan Pareeks PhD project: Detection of Early Atherosclerosis and Arteriosclerosis using Biomarkers and PET/CT (DETECT) in Healthy Controls and Ptt. with Hypertension, Type 2 Diabetes, or Carotid Artery Stenosis. 2013 A two year PhD stipendium (1,050,000 DKkr.) from Danish Diabetes Academy and SDU for Manan Pareek and his PhD project: DETECT 2013 Financial support for a workshop on arterial disease (38,000 DKkr.) from Danish Diabetes Academy (DDA) 2013 Financial support for a PhD course in arterial disease (120,000 DKkr.) from DDA 2013 Financial support from the internationalization put at OUH (90,000 DKkr.) for professor Stephane Laurent 2014 A one year PhD stipendium (500,000 DKkr.) from OUH for Manan Pareek and his PhD project: DETECT 2014 A three-year Post doc stipendium (1,800,000 DKKr.) for Trine Sønder from DDA. 2014 A two year PhD stipendium (1,050,000 DKkr.) from DDA and SDU for Mette Nielsen and her PhD project: HOMA index – As a Prognostic Marker in the General Population and as a Marker of Metabolic Phenotype in Type 2 Diabetes Mellitus (HOMAP-Metabolic) 2014 A one year PhD. stipendium (500,000 DKkr.) from Region of Southern Denmark for the PhD project of Mette Nielsen: HOMAP-Metabolic 2014 Financial support from OUH (288,000 DKkr.) for Mette Nielsens PhD project: HOMAP-Metabolic 2014 A two year PhD. stipendium (1,050,000 DKkr.) from DDA and SDU for Thomas Bastholm Olesen and his PhD project: HOMA2 indexed based Phenotyping in Type 2 Diabetes – Cardiovascular Characteristics – An ITT Substudy (HOMAP-CV) 2014 A one year PhD. stipendium (500,000 DKkr.) from Region of Southern Denmark for PhD project of Thomas Bastholm Olesen: HOMAP-CV. 2014 Financial support (200,000 DKK) for the project of Manan Pareek: Sodium Fluoride and Fluorodeoxyglucose Avidity in Carotid Atheroma: Histopathological Correlates (SOFIA) form Aase og Ejnar Danielsen's Foundation. 2014 Financial support from the internationalization put at OUH (75,000 DKkr.) for professor Peter Nilsson 2015 A one year PhD stipendium (500,000 DKkr.) from OUH to Eva Marie Gram-Kampmanns PhD project: A Reduced- carbohydrate Diet high in Monounsaturated fats in Type 2 Diabetes: a Six-month study of changes in Metabolism and Cardiovascular function (ReDuCtion) 2015 Co-applicant for CAVAC spported by the Region of Southern Denmark with 7,500,000 DKkr. over 5 years. 2015 A two-year PhD stipendium (1,050,000 DKkr.) from DDA and SDU to Eva Marie Gram-Kampmanns and her PhD project: ReDuCtion. 2015 Financial support from the Region of Southern Denmark (730,000 DKkr.) to Eva Marie Gram-Kampmanns PhD project: ReDuCtion. 2015 Financial support to Manan Pareek from SDU (DKkr. 120,000) for a one-year research fellowship at Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts, USA. 2015 Financial support to Manan Pareek from the Region of Southern Denmark and OUH (DKkr. 60,000) for a one- year research fellowship at Brigham and Women’s Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts, USA. 2015 Financial support from Kaarsen Fonden to buy three advanced Mobil-O-Graphs (DKkr. 96,000) 2016 Financial support from International Society of Hypertension to cover travel expenses in relation to the work of the Lancet Commission on Hypertension (Euro 15,000) 2016 Financial support from Kaarsen Fonden to buy a AGE-reader (DKkr. 50,000) 2016 Two-year PhD stipendium from OUH/SDU for the PhD project of Eva Marie Gram-Kampmann: A Reduced- carbohydrate Diet high in Monounsaturated fats in Type 2 Diabetes: a Six-month study of changes in Metabolism and Cardiovascular function (ReDuCtion) 2016- Two-year PhD stipendium from OUH/SDU for the PhD project of Anne-Sofie Allermann Faarvang: “The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered” 2017 Coapplicant for additional CIMA supported by OUH with 14,000,000 DKkr. over 5 years. 2017 Financial support from Regions Zealand/Southern Denmak for Fibulin-1 on SEAS patients (DKkr. 195,845). Publications International peer reviewed papers (178, 40 as 1. author, 37 as last author) and abstracts (144, 50 as 1. author) H-index: 46. i10-index: 103. Number of citations: 19,194. 10 selected puplications 1 Sehestedt T et al., Olsen MH. Risk stratification is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883-91 2 Olsen MH et al. Changes in subclinical organ damage versus Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment. A LIFE Sustudy. J Hypertens 2011;29(5):997-1004. 3 Sehestedt T et al., Olsen MH. Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. J Hypertens. 2012;30(10):1928-36. 4 Vishram JKK et al., Olsen MH. The MORGAM Project. Impact of Age on the Importance of Systolic and Diastolic Blood Pressures for Stroke Risk. Hypertension 2012;60(5):1117-1123. 5 Mancia G et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. Eur Heart J. 2013;34(28):2159-219 6 Vishram JKK et al., Olsen MH. Do other cardiovascular risk factors influence the impact of age on the association between blood pressure and mortality? The MORGAM Project. J Hypertens. 2014;32(5):1025-33. 7 Greve SV et al., Olsen MH. Effective risk stratification in patients with moderate cardiovascular risk using albuminuria and atherosclerotic plaques in the carotid arteries. J Hypertens.2015; 33:1563-7 8 Pareek M et al., Olsen MH. Worsening diastolic function is associated with elevated fasting plasma glucose and increased left ventricular mass in a supra-additive fashion in an elderly, healthy, Swedish population. Int J Cardiol. 2015;184:466-72. 9 Olsen MH et al. A call to action and a life-course strategy to address the global burden of raised blood pressure on current and future generations. The Lancet Commission on Hypertension. Lancet 2016;388(10060):2665-2712 10 Pareek M, Bhatt DL, Nielsen ML, Jagannathan R, Eriksson KF, Nilsson PM, Bergman M, Olsen MH. Enhanced Predictive Capability of a 1- Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study. Diabetes Care. 2017 Nov 14.